Skip to main content

Incident Use of Rivaroxaban

Basic Details
Date Posted
Status
Complete
Medical Product
rivaroxaban
Description

This report investigates exposure to rivaroxaban among all patients in the Mini-Sentinel Distributed Database (MSDD) and among members with a pre-existing condition of atrial fibrillation and atrial flutter. Data from July 1, 2011 to September 30, 2013 from 18 Data Partners contributing to the MSDD were included in this request. The request was distributed to Data Partners on November 22, 2013.

Deliverables (1)
Mini-Sentinel Modular Program Report: Incident Use of Rivaroxaban
Additional Details
FDA Center
CDER
Time Period
July 1, 2011 - September 30, 2013
Analysis Type
Mini-Sentinel
Population / Cohort
All individuals
Data Sources
Mini-Sentinel Distributed Database (MSDD)